NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame.
A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss.
Yet Jobling’s experience also has altered his perspective on dieting. He now sees obesity as a disease that requires medical intervention, not just behavioral changes. In fact, he thinks he will need to stay on a drug like Wegovy for the rest of his life even though it has taken some of the joy out of eating.
José Raúl Mulino: Panama’s new president
Kendrick Lamar calls Drake a PEDOPHILE in new diss track as their war of words heats up
Police search for suspects after 7 wounded, 4 critically, in shooting in Long Beach, California
Celebrating excellence in journalism and the arts, Pulitzer Prizes to be awarded Monday
Scientists are learning the basic building blocks of sperm whale language after years of effort
Qantas agrees to pay $79 million in compensation and a fine for selling seats on canceled flights
Are you having enough sex? Our intimacy coach reveals eight ways to have more
Sparks move home game against Caitlin Clark and Indiana from Long Beach to downtown Los Angeles
Sierra Nevada records snowiest day of the season
The Titans bolster wide receiving group by adding Tyler Boyd, AP source says
Raleigh's 9th inning homer gives Mariners 5